Home > Insider Trading > Filing (0001209191-20-009365)

Filing Details

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
921299	Fibrogen Inc	FGEN	Pharmaceutical Preparations (2834)	000000000

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1775295	Christine Chung	C/O Fibrogen, Inc. 409 Illinois St. San Francisco CA 94158	Svp, China Operations	No	Yes	No	No

Reported Non-Derivative Transactions

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership
Common Stock	Acquisiton	2020-02-11	5,625	$25.40	138,269	No	4	M	Direct
Common Stock	Disposition	2020-02-11	5,625	$44.48	132,644	No	4	S	Direct
Common Stock	Acquisiton	2020-02-12	5,625	$25.40	138,269	No	4	M	Direct
Common Stock	Disposition	2020-02-12	5,025	$45.94	133,244	No	4	S	Direct
Common Stock	Disposition	2020-02-12	600	$46.28	132,644	No	4	S	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership
No	4	M	Direct
No	4	S	Direct
No	4	M	Direct
No	4	S	Direct
No	4	S	Direct

Reported Derivative Transactions

Sec. Name	Sec. Type	Acquisiton - Disposition	Date	Amount	Price	Amount - 2	Price - 2
Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-11	5,625	$0.00	5,625	$25.40
Common Stock	Stock Option (Right to Buy)	Disposition	2020-02-12	5,625	$0.00	5,625	$25.40

Remaning Holdings	Exercise Date	Expiration Date	Equity Swap Involved	Transaction Form Type	Transaction Code	Nature of Ownership
48,089		2027-03-08	No	4	M	Direct
42,464		2027-03-08	No	4	M	Direct

Footnotes

Shares sold pursuant to a 10b5-1 plan.
The shares were sold at prices ranging from $43.77 to $44.71. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $45.22 to $46.21. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
The shares were sold at prices ranging from $46.22 to $46.435. The reporting person will provide upon request to the SEC, the issuer or security holder of the issuer, full information regarding the number of shares sold at each separate price.
Twenty-five percent of the shares subject to the option vested on March 1, 2018, and the remainder vested in equal amounts quarterly thereafter for the following three years.